Skip to search boxSkip to navigationSkip to main content

Snail as a potential target molecule in cardiac fibrosis: Paracrine action of endothelial cells on fibroblasts through snail and CTGF Axis

  • Sae Won Lee
    ,
  • Joo Yun Won
    ,
  • Woo Jean Kim
    ,
  • Jaewon Lee
    ,
  • Kyung Hee Kim
    ,
  • Seock Won Youn
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Ischemia/reperfusion (I/R) injury to myocardium induces death of cardiomyocytes and destroys the vasculature, leading to cardiac fibrosis that is mainly mediated by the transdifferentiation of fibroblasts to myofibroblasts and the collagen deposition. Snail involvement in fibrosis is well known; however, the contribution of Snail to cardiac fibrosis during I/R injury and its underlying mechanisms have not been defined. We showed that I/R injury to mouse hearts significantly increases the expression of Snail. An in vitro hypoxia/reoxygenation (Hy/Reoxy) experiment showed that the cell source of Snail induction is endothelial cells rather than cardiac fibroblasts (cFibroblasts) or cardiomyoblasts. When Snail was overexpressed in endothelial cells, they underwent endothelial-to-mesenchymal transition (EndMT) but showed very poor capacity for collagen synthesis. Instead, reoxygenation- or Snail overexpression-mediated EndMT-like cells noticeably stimulated transdifferentiation of fibroblasts to myofibroblasts via secretion of connective tissue growth factor (CTGF). The injection of a peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist, a selective Snail inhibitor, remarkably suppressed collagen deposition and cardiac fibrosis in mouse I/R injury, and significantly improved cardiac function and reduced Snail and CTGF expression in vivo. Our findings suggested a new mechanism of cell-to-cell communication between EndMT-like cells and fibroblasts for fibrosis induction and implicated Snail as a potential target molecule in cardiac fibrosis after I/R injury.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1767-1777 (11 pages)

Journal (Volume, Issue Number)

Molecular Therapy (Volume 21, Issue 9)

Publication milestones

  • Published - 09/2013

Publication status

Published - 09/2013

ISSN

1525-0016

Publication IDs

  • Scopus: 84883739507
  • PubMed: 23760445

Publication metrics

Metrics

SciVal
FWCI
1.96
SciVal
Author count
11
SciVal
citations
59
SciVal
Paper percentile
94
SciVal
Top percentile
10
Scopus
citations
Fractional count
1
Fractional count
0.09
Fractional count
10
Fractional count
0.91
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Social media
2
Captures
87
Citation count
90

Funding Details

This research was supported by a grant from the Innovative Research Institute for Cell Therapy (A062260); National Research Foundation (NRF) grant funded by the Korea Government (2010-0024252 to S.-W.L.; 2010-0020258 to H.-S.K.); and grant No. R31-2008-000-10103-0 from the World Class University program of the NRF. The authors declared no conflict of interest.
FundersFunding numbers
Innovative Research Institute for Cell Therapy
A062260
NRF
2010-0020258, 2010-0024252, R31-2008-000-10103-0